Sentences with phrase «studying treatments for»

The nonobese diabetic (NOD) mouse is a common model used for studying treatments for diabetes.

Dr. Bira is an assistant professor in the Department of Psychiatry within UT Health San Antonio's Joe R. & Teresa Lozano Long School of Medicine, where she works with the STRONG STAR research consortium studying treatments for post-traumatic stress disorder.

Then there's the larger question of whether science should study treatments for a condition that is not, in mental health terms, a problem.

Vincristine was also not part of the study treatment for the elderly patients.

At this point this is the most studied treatment for PTSD and most studied by centers other then the center that created the concept.

Not exact matches

Lilly faced a devastating clinical setback last year with a late - stage failure for its experimental Alzheimer's treatment, the studies for which cost the company hundreds of millions of dollars.

Furthermore, an early - stage study pumping up the dose of its hemophilia A treatment — which aims to be a one - time therapy for the rare blood clotting - related disease — appeared to hit its targets without serious side effects.

At Battelle, Koper is studying the use of nanomaterials in membranes for water desalination and treatment; supercapacitors (energy - storage devices that provide higher power densities than batteries); and bio-based (rather than petroleum - based) additives used for hydraulic fracturing, or fracking, to retrieve natural gas.

VICE News made numerous email and telephone queries over the past month to spokespeople for the Army, the Navy, and the Department of Defense seeking comment on the Army Institute of Public Health study and the treatment of troops before and after their deployment to Guantanamo.

Private hospitals are typically the best equipped, with state - of - the art technology and doctors that have studied in the world's best medical universities — many of them speak English and are well acquainted with the newest diagnostic and treatment procedures... some of which may not yet be available in the U.S., for example.

While the research was aimed at eventually developing treatments for those suffering from PTSD, the study authors said these initial findings were also useful for those of us who just have to deal with normal negativity like marital spats and nasty work disagreements.

Once the final results of those studies are analyzed this spring — and the early evidence has been encouraging — the challenge will be to get FDA approval for human trials and then bring the treatment to market.

The study is particularly encouraging because autism diagnoses are currently done on children between the ages of two and four, and earlier diagnoses allows for more effective treatment measures.

The company is chasing an at least $ 80 million IPO to help fund the phase 3 studies that would be necessary for the Food and Drug Administration (FDA) to clear the treatment (the company has made modifications to the experimental, once - a-day pill that fights brain plaque buildup associated with Alzheimer's).

The study is patient - funded; participants, who range in age from late 30s through 80s, must pay $ 8,000 to take part, and live in or travel to Monterey for treatments and follow - up assessments.

The Food and Drug Administration (FDA) has given Alnylam Pharmaceuticals the green light to relaunch clinical trials of its treatment for the bleeding disorder hemophilia after pausing the studies after a patient death.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

«Based on the results from these Phase 3 studies, the combination of bictegravir and FTC / TAF could represent an important advance in triple - therapy treatment for a broad range of HIV patients, and we look forward to submitting regulatory applications in the U.S. and EU this year.»

Chicago, GenomeWeb — A new study by researchers from Memorial Sloan Kettering Cancer Center has demonstrated the predictive power of an AR - V7 protein expression test using Epic Sciences» non-EPCAM-based circulating tumor cell detection platform, which could help guide treatment decisions for men with metastatic castration - resistant prostate cancer.

The drug known by the street names Ecstasy or Molly could be a promising treatment for post-traumatic stress disorder, according to a new study.

Join us for key insights from the CoMMpass Study, including results that patients and caregivers may find helpful for treatment decisions.

This test confirmed a significant positive effect of treatment on investment in high variance stocks, both for the cortisol administration study (z = 2.37, P = 0.018) and the testosterone administration study (z = 2.04, P = 0.041, see Fig.

The products are being studied as treatments for skin cancer, recurrent ovarian cancer and high LDL, or bad cholesterol, that doesn't respond to pills such as Lipitor.

According to a recent study by David Macdonald of the Canadian Centre for Policy Alternatives, almost all of the tax benefit of special tax treatment of dividends (91 %) goes to the top one tenth of all tax filers.

The biotech specialist said that its updated phase 2 data in a study of its poziotinib candidate treatment for non-small cell lung cancer resulted in a preliminary confirmed objective response rate and potential progression - free survival benefit in patients with the EGFR Exon 20 Mutant form of the disease.

Corbus» top - line data from a 22 - patient study of anabasum for the treatment of...

Although the biotech has only conducted preclinical studies so far, there are several potential advantages to nonviral therapies, including being quicker to develop and possibly eliminating the need for a lengthy monitoring period of patients after treatment.

Patisiran was being evaluated in a late - stage study against a placebo for the treatment of patients with hereditary ATTR (hATTR) amyloidosis with polyneuropathy.

Investors are therefore going to have to wait for the final ongoing study to wrap up in order to get any real insight into ALKS - 5461's fate as a treatment for MDD.

Lest common sense fail to convince readers that surgery is not a treatment for a mental disorder, a Swedish study published in 2011 found that over the long term, 324 people who had undergone sex - reassignment surgery demonstrated an alarmingly high suicide rate and experienced considerably higher numbers of severe psychiatric problems than were present in the general population.

Many of the things he said, the way he said them... he did not study the same as I did for certain, and anyone who believes they converse with god, should not be involved with anyone elses treatment.

There is knowledge to be gained by such studies, of course, but it hardly makes for the sort of case embryo - research advocates were advancing just a few years ago — with its miracle cures and treatments for the untreatable.

It is, for example, well worth while studying his treatment of women and of the underprivileged.

If the disease appeared to be simply functional, the applicant was registered for treatment and directed to the rector's study.

Professor Steve Odin's «A Metaphysics of Cumulative Penetration: Process Theory and Hua - yen Buddhism» (PS 11:65 - 82), is a highly stimulating and challenging essay not only for Whiteheadian and Buddhist studies, but also for its comparative value.1 He has presented a searching analysis of Whiteheadian metaphysics of cumulative penetration, but his treatment of Buddhism in general and Hua - yen in particular in terms of that metaphysics leaves much to be desired, thereby marring the comparative nature of the whole essay.

Professor Steve Odin's «A Metaphysics of Cumulative Penetration: Process Theory and Hua - yen Buddhism» (PS 11:65 - 82), is a highly stimulating and challenging essay not only for Whiteheadian and Buddhist studies, but also for its comparative value.1 He has presented a searching analysis of Whiteheadian metaphysics of cumulative penetration, but his treatment of Buddhism in general and...

For detailed instructions for using this exercise in sexual therapy (and enrichment) see William Hartmann and Virginia Fifthian's Treatment of Sexual Dysfunction (Long Beach, Calif.: Center for Marital and Sexual Studies, 1972), pp. 98 - 1For detailed instructions for using this exercise in sexual therapy (and enrichment) see William Hartmann and Virginia Fifthian's Treatment of Sexual Dysfunction (Long Beach, Calif.: Center for Marital and Sexual Studies, 1972), pp. 98 - 1for using this exercise in sexual therapy (and enrichment) see William Hartmann and Virginia Fifthian's Treatment of Sexual Dysfunction (Long Beach, Calif.: Center for Marital and Sexual Studies, 1972), pp. 98 - 1for Marital and Sexual Studies, 1972), pp. 98 - 138.

In 1965, he published his most famous book, at once classic and immediately consequential as a study in the development of doctrine: Contraception: A History of Its Treatment by the Catholic Theologians and Canonists — 533 pages of dazzling historical research, unpretentious erudition, and contextual analysis that concluded by offering reasons why the papal magisterium could and should support some forms of contraception for married couples.

(For a comprehensive discussion of the use of alcohol as a religious substitute, see «Philosophical - Religious Factors in the Etiology and Treatment of Alcoholism,» by H. J. Clinebell, Jr., Quarterly Journal of Studies on Alcohol (Fall, 1965).

I've been away for a while, taking a bit of an unannounced break to focus on my health treatment and studies.

While raw honey and manuka honey are the preferred options for canker sore and wound treatment, a study in Saudi Arabia studied the use of commercial honey to treat canker sores.

«When farms sign on for verification, we create case studies applying the 5P's to eight separate categories of sustainability: pest management, good employee practices, soil treatments, climate / energy, water, waste, packaging and community support.

Other studies show that the goji berry benefits eye health by protecting the retina from ganglion cells so goji antioxidants act as a natural treatment for glaucoma.

Another study published earlier this year (2013) in Malaysia showed that topical formulas containing coconut oil in a gel base was a superior treatment for wounds and bacterial infections.

Even though honey has been used for the treatment of ailments since ancient times, it is only in relatively recent years that scientific studies and analysis of the benefits of manuka honey have been undertaken.

Ironically, a saturated fat (virgin coconut oil) may prove to be the safest and most effective treatment for NAFLD according to a study published recently (September 2017) in the Journal of the Science and Agriculture of Food.

The researchers could not pinpoint the duration of protection exhibited but said they were encouraged that the study will lead to long - lasting treatments for food allergies.

Chia is being studied as a potential natural treatment for type - 2 diabetes because of its ability to slow down digestion.

Capsaicin, the substance that gives chiles their fire, is being studied as an effective treatment for sensory nerve fiber disorders, including pain associated with arthritis,

Potential subjects were accepted into the study if they had none of the following conditions: severe or symptomatic cardiac disease or hypertension; history of bleeding disorders; chronic history of gastric, intestinal, liver, pancreatic, or renal disease; any portion of the stomach or the intestine removed (other than an appendectomy); history of intestinal obstruction, malabsorption, or use of antacid drugs; cancer (active or use of medications for a history of cancer treatment within the past 5 y); history of chronic alcoholism; a convulsive disorder; or abnormal results in screening blood or urine samples.